Tuesday, October, 15, 2019 10:39:23

Contribution By Akshay Kedari


Health & Nutrition

Chembio’s Point-of-Care Multiplex Test approved by Brazil’s ANVISA

Globally reputed point-of-care diagnostics company, Chembio Diagnostics, Inc., has apparently declared that Brazil’s health regulatory agency, ANVISA (Agência Nacional de Vigilância Sanitária), in collaboration with Bio-Manguinhos/Fiocruz, has approved its DPP Zika/Dengue/Chikungunya System. Speaking on the disease detection scenario in Brazil, John Sperzel, CEO, Chembio, stated …